Daniel V, Süsal C, Weimer R, Zimmermann R, Huth-Kühne A, Opelz G
Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-69120, Heidelberg, Germany.
Immunol Lett. 2001 Mar 1;76(2):69-78. doi: 10.1016/s0165-2478(01)00181-x.
There is evidence that HIV induces CD4+ depletion in part by the formation of immune complexes (IC) that attach to CD4+ blood lymphocytes. In the present study we examined the relationship of IC-coated CD4+ blood cells with retroviral replication in HAART-treated patients.
52 hemophilia patients were studied from 1997 to 1999. Lymphocyte subsets, IgM, IgG and gp120 on CD4+ blood cells, in vitro responses of lymphocytes to mitogens, plasma neopterin and plasma viral load were measured.
Patients with detectable viral replication and without ICs on CD4+ blood lymphocytes had a lower viral load (4100 versus 21000 HIV-1 mRNA copies/ml; P = 0.079) and higher CD4+ cell counts (310/microl versus 161/microl; P = 0.035) than patients with ICs on circulating CD4+ lymphocytes. Among patients with < 80 HIV-1 mRNA copies/ml, IC- individuals had slightly higher CD4+ lymphocyte counts than IC+ patients (384/microl versus 316/microl; n.s.). Further evidence for the clinical relevance of the ICs was obtained when 18 patients who had an undetectable viral load at previous investigations were analyzed. Among patients with a stable undetectable viral load, CD4+ counts increased in 6 of 8 IC- but in none of 2 IC+ individuals. In patients whose viral load increased during the observation period, 5 of 6 IC- but none of 2 IC+ individuals showed higher CD4+ cell counts. Impaired virus killing is suggested by lower CD16+ (35/microl versus 107/microl; P = 0.016), higher CD3+ DR+ (178/microl versus 66/microl; P = 0.006), and higher CD8+ DR+ (142/microl versus 34/microl; P = 0.017) cell counts in IC(-) patients compared to IC- patients without detectable viral load. Strong retroviral replication induced strong T cell dysfunctions. Fewer CD3+ 25+ blood lymphocytes (19/microl versus 47/microl; P = 0.006) and a lower in vitro response of T lymphocytes to the mitogens Con A (RR: 0.3 versus 1.2; P=0.023) and CD3 mab (RR: 0.5 versus 2.4; P = 0.012) was observed in IC+ patients with detectable versus undetectable viral load.
Our data suggest that ICs on circulating CD4+ blood lymphocytes are primarily associated with CD4+ lymphocyte depletion whereas the plasma viral load is primarily associated with decreased T lymphocyte activation, lower CD16+ counts, and higher CD8+ DR+ lymphocytes which might be the effector cells for virus elimination.
有证据表明,HIV 部分通过形成附着于 CD4⁺ 血液淋巴细胞的免疫复合物(IC)来诱导 CD4⁺ 细胞耗竭。在本研究中,我们检测了接受高效抗逆转录病毒治疗(HAART)的患者中,IC 包被的 CD4⁺ 血细胞与逆转录病毒复制之间的关系。
1997 年至 1999 年对 52 例血友病患者进行了研究。检测淋巴细胞亚群、CD4⁺ 血细胞上的 IgM、IgG 和 gp120、淋巴细胞对有丝分裂原的体外反应、血浆新蝶呤和血浆病毒载量。
与循环 CD4⁺ 淋巴细胞上有 IC 的患者相比,CD4⁺ 血液淋巴细胞上可检测到病毒复制且无 IC 的患者病毒载量较低(4100 对 21000 HIV-1 mRNA 拷贝/ml;P = 0.079),CD4⁺ 细胞计数较高(310/μl 对 161/μl;P = 0.035)。在 HIV-1 mRNA 拷贝/ml < 80 的患者中,IC⁻ 个体的 CD4⁺ 淋巴细胞计数略高于 IC⁺ 患者(384/μl 对 316/μl;无显著性差异)。对 18 例先前检测病毒载量不可测的患者进行分析时,获得了关于 IC 临床相关性的进一步证据。在病毒载量稳定不可测的患者中,8 例 IC⁻ 患者中有 6 例 CD4⁺ 计数增加,而 2 例 IC⁺ 患者中无一例增加。在观察期内病毒载量增加的患者中,6 例 IC⁻ 患者中有 5 例 CD⁺ 细胞计数升高,而 2 例 IC⁺ 患者中无一例升高。与病毒载量不可测的 IC⁻ 患者相比,IC⁺ 患者 CD16⁺ 细胞计数较低(35/μl 对 107/μl;P = 0.016)、CD3⁺DR⁺ 细胞计数较高(178/μl 对 66/μl;P = 0.006)以及 CD8⁺DR⁺ 细胞计数较高(142/μl 对 34/μl;P = 0.017),提示病毒杀伤受损。强烈的逆转录病毒复制诱导强烈的 T 细胞功能障碍。在病毒载量可测与不可测的 IC⁺ 患者中,观察到 CD3⁺25⁺ 血液淋巴细胞较少(19/μl 对 47/μl;P = 0.006),T 淋巴细胞对有丝分裂原刀豆蛋白 A(RR:0.3 对 1.2;P = 0.023)和 CD3 单克隆抗体(RR:0.5 对 2.4;P = 0.012)的体外反应较低。
我们的数据表明,循环 CD4⁺ 血液淋巴细胞上的 IC 主要与 CD4⁺ 淋巴细胞耗竭有关,而血浆病毒载量主要与 T 淋巴细胞激活降低、CD16⁺ 计数降低以及 CD8⁺DR⁺ 淋巴细胞增多有关,后者可能是病毒清除的效应细胞。